Atherosclerosis Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global atherosclerosis drugs market is expected to grow at a CAGR of around 2.5% during 2025-2034. This report on global atherosclerosis drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global atherosclerosis drugs market by segmenting the market based on type, route of administration, distribution channel and region. Also, detailed profiles of companies operating in the atherosclerosis drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Increasing Awareness about Cardiovascular Diseases
Market Challenges
• Low Diagnostic Rate
Historical & Forecast Period
Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034
Market by Type
• Anti-platelet and Anticoagulants
• Cholesterol Lowering Medication
• ACE Inhibitors
• Beta Blockers
• Other Drug Types
Market by Route of Administration
• Oral
• Injectable
Market by Route of Administration
• Hospital Pharmacies
• Online Providers
• Drug Stores and Retail Pharmacies
Market by Distribution Channel
• Consumer Electronics
• Healthcare
• Aerospace and Defense
• Telecommunication
• Other Distribution Channels
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Atherosclerosis Drugs Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Atherosclerosis Drugs Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Type
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Atherosclerosis Drugs Market by Type
- 5.1. Introduction
- 5.2. Anti-platelet and Anticoagulants
- 5.3. Cholesterol Lowering Medication
- 5.4. ACE Inhibitors
- 5.5. Beta Blockers
- 5.6. Other Drug Types
- 6. Global Atherosclerosis Drugs Market by Route of Administration
- 6.1. Introduction
- 6.2. Oral
- 6.3. Injectable
- 7. Global Atherosclerosis Drugs Market by Distribution Channel
- 7.1. Introduction
- 7.2. Hospital Pharmacies
- 7.3. Online Providers
- 7.4. Drug Stores and Retail Pharmacies
- 8. Global Atherosclerosis Drugs Market by Region
- 8.1. Introduction
- 8.2. Europe
- 8.2.1. Germany
- 8.2.2. United Kingdom
- 8.2.3. France
- 8.2.4. Italy
- 8.2.5. Spain
- 8.2.6. Russia
- 8.2.7. Netherlands
- 8.2.8. Rest of the Europe
- 8.3. North America
- 8.3.1. United States
- 8.3.2. Canada
- 8.4. Asia Pacific
- 8.4.1. China
- 8.4.2. Japan
- 8.4.3. India
- 8.4.4. South Korea
- 8.4.5. Australia
- 8.4.6. Indonesia
- 8.4.7. Rest of the Asia Pacific
- 8.5. Latin America
- 8.5.1. Mexico
- 8.5.2. Brazil
- 8.5.3. Argentina
- 8.5.4. Rest of Latin America
- 8.6. Middle East & Africa
- 8.6.1. Saudi Arabia
- 8.6.2. Turkey
- 8.6.3. Iran
- 8.6.4. United Arab Emirates
- 8.6.5. Rest of Middle East & Africa
- 9. SWOT Analysis
- 10. Porter’s Five Forces
- 11. Market Value Chain Analysis
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Company Profiles
- 12.2.1. Amgen Inc.
- 12.2.2. AstraZeneca
- 12.2.3. Bausch Health Companies Inc.
- 12.2.4. Bayer AG
- 12.2.5. Eli Lilly and Company
- 12.2.6. GlaxoSmithKline Plc
- 12.2.7. Johnson & Johnson
- 12.2.8. Lupin
- 12.2.9. Merck & Co., Inc.
- 12.2.10. Novartis AG
- 12.2.11. Pfizer Inc.
- 12.2.12. Regeneron Pharmaceuticals, Inc.
- 12.2.13. Sanofi
- 12.2.14. Viatris (Mylan N.V.)
- List of Figures
- Figure 1: Global Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 2: Global Atherosclerosis Drugs Market by Type, 2024
- Figure 3: Global Atherosclerosis Drugs Market by Route of Administration, 2024
- Figure 4: Global Atherosclerosis Drugs Market by Distribution Channel, 2024
- Figure 5: Global Atherosclerosis Drugs Market by Region, 2024
- Figure 6: Global Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 7: Global Atherosclerosis Drugs Market by Type (in %), 2024 & 2034
- Figure 8: Global Anti-platelet and Anticoagulants Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 9: Global Anti-platelet and Anticoagulants Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 10: Global Cholesterol Lowering Medication Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 11: Global Cholesterol Lowering Medication Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 12: Global ACE Inhibitors Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 13: Global ACE Inhibitors Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 14: Global Beta Blockers Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 15: Global Beta Blockers Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 16: Global Other Drug Types Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 17: Global Other Drug Types Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 18: Global Atherosclerosis Drugs Market by Route of Administration (in %), 2024 & 2034
- Figure 19: Global Oral Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 20: Global Oral Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 21: Global Injectable Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 22: Global Injectable Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 23: Global Atherosclerosis Drugs Market by Distribution Channel (in %), 2024 & 2034
- Figure 24: Global Hospital Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 25: Global Hospital Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 26: Global Online Providers Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 27: Global Online Providers Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 28: Global Drug Stores and Retail Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 29: Global Drug Stores and Retail Pharmacies Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 30: Global Atherosclerosis Drugs Market by Region (in %), 2024 & 2034
- Figure 31: Europe Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 32: Europe Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 33: Europe Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
- Figure 34: Germany Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 35: United Kingdom Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 36: France Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 37: Italy Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 38: Spain Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 39: Russia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 40: Netherlands Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 41: North America Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 42: North America Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 43: North America Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
- Figure 44: United States Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 45: Canada Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 46: Asia Pacific Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 47: Asia Pacific Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 48: Asia Pacific Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
- Figure 49: China Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 50: Japan Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 51: India Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 52: South Korea Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 53: Australia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 54: Indonesia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 55: Latin America Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 56: Latin America Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 57: Latin America Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
- Figure 58: Mexico Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 59: Brazil Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 60: Argentina Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 61: Middle East & Africa Atherosclerosis Drugs Market (in US$ Million), 2020-2024
- Figure 62: Middle East & Africa Atherosclerosis Drugs Market (in US$ Million), 2025-2034
- Figure 63: Middle East & Africa Atherosclerosis Drugs Market by Country (in %), 2024 & 2034
- Figure 64: Saudi Arabia Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 65: Turkey Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 66: Iran Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 67: UAE Atherosclerosis Drugs Market (in US$ Million), 2020-2034
- Figure 68: Market Value Chain
- List of Tables
- Table 1: Global Atherosclerosis Drugs Market Portraiture
- Table 2: Global Atherosclerosis Drugs Market by Type (in US$ Million), 2024 & 2034
- Table 3: Global Atherosclerosis Drugs Market by Route of Administration (in US$ Million), 2024 & 2034
- Table 4: Global Atherosclerosis Drugs Market by Distribution Channel (in US$ Million), 2024 & 2034
- Table 5: Global Atherosclerosis Drugs Market by Region (in US$ Million), 2024 & 2034
- Table 6: Europe Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 7: North America Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 8: Asia Pacific Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 9: Latin America Atherosclerosis Drugs Market by Country (in US$ Million), 2024 & 2034
- Table 10: Middle East & Africa Atherosclerosis Drugs Market by Country (in US$ Million),
- 2024 & 2034
- Table 11: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook